Mainstream

Mineralys plans nda submission for lorundrostat following pivotal hypertension data and $201m equity raise

Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise

Mineralys plans NDA submission for lorundrostat following pivotal hypertension data and $201M equity raise

Post ContentmlysRead More

You might also be interested in reading SpaceX stock nears $107 support before earnings, unlock.

May 13, 2025
In Mainstream